Amygdala α-Synuclein Pathology in the Population-Based Vantaa 85+ Study.

Area of Science:

• Neuropathology
• Neurodegenerative Diseases
• Aging Research

Background:

• Lewy-related pathology (LRP) is a hallmark of Lewy body dementia (DLB).
• The amygdala's role in LRP and its association with dementia subtypes requires further investigation.
• Population-based studies are crucial for understanding the prevalence of neurodegenerative pathologies.

Purpose of the Study:

• To determine the frequency of Lewy-related pathology (LRP) in the amygdala.
• To compare amygdala LRP with LRP and Alzheimer's disease (AD) pathology in other brain regions.
• To assess the association of amygdala LRP with dementia and its independence as a risk factor.

Main Methods:

• Analysis of amygdala samples (N=304) from the population-based Vantaa 85+ study.
• Immunostaining using two alpha-synuclein antibodies (clone 42 and clone 5G4).
• Comparison of amygdala LRP data with previously analyzed pathologies in other brain regions.

Main Results:

• Amygdala LRP was detected in 33% of subjects.
• Pure AD subjects showed 5% amygdala LRP, while pure DLB subjects had 85% amygdala LRP.
• Amygdala LRP was associated with dementia, but this association was dependent on LRP in other brain regions, not an independent factor.

Conclusions:

• Lewy-related pathology in the amygdala is common but not an independent predictor of dementia.
• The presence of LRP in other brain regions is necessary for amygdala LRP to be associated with dementia.
• Amygdala-predominant LRP is a rare and heterogeneous finding.